| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161597 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia; |
| 07/12/2007 | US20070161596 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy |
| 07/12/2007 | US20070161589 DNA, RNA or chimeric oligonucleotide that is at least 90% complementary the nucleic acid encoding CD40 antigens, used for inhibiting the expression of CD40 in cells or tissues; antitumor and antiproliferative agents |
| 07/12/2007 | US20070161584 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein |
| 07/12/2007 | US20070161576 Drugs for chronic pains |
| 07/12/2007 | US20070161575 Inhibiting the replication of hepatitis C virus, therapy, infections |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | US20070161573 Selective targeting agents for mitochondria |
| 07/12/2007 | US20070161572 Drug therapy for Celiac Sprue |
| 07/12/2007 | US20070161571 Prevents the aggregation of LHRH antagonists in solutions; bioavailability |
| 07/12/2007 | US20070161570 Inducing immunosupressed condition or treating chronic allograft vasculopathy in subject undergoing transplant by administering, for example, {(3R,4S,5S,6R)-5-Methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 07/12/2007 | US20070161569 Conformationally constrained parathyroid hormones with alpha-helix stabilizers |
| 07/12/2007 | US20070161568 Use of GLP-1 peptides |
| 07/12/2007 | US20070161567 Administering parathyroid hormone; crystal proteins; for treatment of osteoporosis |
| 07/12/2007 | US20070161566 Method of treating multiple sclerosis |
| 07/12/2007 | US20070161565 Signal transduction protein TAB2 |
| 07/12/2007 | US20070161564 Methods for making Apo-2 ligand using divalent metal ions |
| 07/12/2007 | US20070161563 A device for enhanced epithelial permeation of y2 receptor-binding peptides |
| 07/12/2007 | US20070161562 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
| 07/12/2007 | US20070161561 Factor vii and factir ix polypeptide; blood coagulation; blood disorders |
| 07/12/2007 | US20070161560 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/12/2007 | US20070161559 Method for the treatment of gout or pseudogout |
| 07/12/2007 | US20070161558 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same |
| 07/12/2007 | US20070161557 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia |
| 07/12/2007 | US20070161556 Antifungal Therapeutic targets |
| 07/12/2007 | US20070161555 Administering adrenomedullin for inhibiting abnormal bradykinin-induced myometrial contraction |
| 07/12/2007 | US20070161554 Treatment of neurodegenerative diseases by the use of laptm4b |
| 07/12/2007 | US20070161553 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation |
| 07/12/2007 | US20070161552 Use of low-dosage erythropoietin for stimulation of endothelial progenitor cells, for organ regeneration and for slowing the progression of end-organ damage |
| 07/12/2007 | US20070161551 Methods and compositions for the treatment of lipodystrophy |
| 07/12/2007 | US20070161550 Antiviral compositions which inhibit paramyxovirus infection |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070161548 diagnosing a pregnant woman at increased risk of preeclampsia; HELLP (hemolysis, elevated liver enzymes; contacting the sample with an antibody that specifically binds a marker |
| 07/12/2007 | US20070161546 Methods and compositions for treatment of cancer |
| 07/12/2007 | US20070161545 Triple polypeptide complexes |
| 07/12/2007 | US20070161544 Selective targeting agents for mitcochondria |
| 07/12/2007 | US20070161543 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 07/12/2007 | US20070161542 Ptb1b photoprobes |
| 07/12/2007 | US20070161541 For treatment or prevent of autoimmune, neurodegenerative and immune hypersensitivity disorders such as Alzheimer's disease, multiple sclerosis, rheumatoid arthritis, allergy, stroke or chronic fatigue syndrome |
| 07/12/2007 | US20070161540 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
| 07/12/2007 | US20070161122 Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the same |
| 07/12/2007 | US20070161083 Codon Optimized Recombinant Dermaphagoides Allergens |
| 07/12/2007 | US20070161081 Hepatocyte growth factor intron fusion proteins |
| 07/12/2007 | US20070161080 Antibodies |
| 07/12/2007 | US20070161063 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/12/2007 | US20070161061 Novel composition and methods for the treatment of immune related diseases |
| 07/12/2007 | US20070161060 Screening method for identifying an agent that modulates PIPKIgamma trafficking of E-cadherin |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070161040 Hybrid proteins of active-site serine beta-lactamase |
| 07/12/2007 | US20070161034 Compositions and methods for the therapy and diagnosis of colon cancer |
| 07/12/2007 | US20070161021 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 07/12/2007 | US20070161002 Growth differentiation factor promoter and uses therefor |
| 07/12/2007 | US20070160987 Human g protein-coupled receptor and modulators thereof for the treatment of inflammatory disorders |
| 07/12/2007 | US20070160982 Development of influenza a antivirals |
| 07/12/2007 | US20070160981 Viral protease |
| 07/12/2007 | US20070160744 Method for attaching two surfaces to each other using a bioadhesive polyphenolic protein and periodate ions |
| 07/12/2007 | US20070160697 Cancer metastasis inhibitory composition |
| 07/12/2007 | US20070160681 Bone graft and scaffolding materials immobilized with osteogenesis enhancing peptides on the surface |
| 07/12/2007 | US20070160679 Repair of ruptured membrane by injection of naturally occurring protein in amniotic fluid |
| 07/12/2007 | US20070160658 Delivery system for diagnostic and therapeutic agents |
| 07/12/2007 | US20070160620 Immune responses using compositions containing stress proteins |
| 07/12/2007 | US20070160618 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 07/12/2007 | US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 07/12/2007 | US20070160611 Administering a mammal an IL-31RA or OSMRb (Oncostatin M receptor beta) antagonist, wherein such antagonist is an antibody or soluble receptor to treat the inflammation by reducing, limiting, minimizing or neutralizing stimulation in neuronal tissues |
| 07/12/2007 | US20070160609 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/12/2007 | US20070160608 Treatment with anti-vegf antibodies |
| 07/12/2007 | US20070160607 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/12/2007 | US20070160606 Treating renal cell carcinoma with an anti-TNF human antibody or fragment |
| 07/12/2007 | US20070160602 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160593 Sugar chain-cleaving agent |
| 07/12/2007 | US20070160592 Method for treatment of macular degeneration |
| 07/12/2007 | US20070160591 Peri-operative and peri-procedure nutritional supplementation |
| 07/12/2007 | US20070160590 Metabolic uncoupling therapy |
| 07/12/2007 | US20070160580 Interferon gamma therapies for idiopathic pulmonary fibrosis |
| 07/12/2007 | US20070160579 Methods of modulating a mammalian cytokine |
| 07/12/2007 | US20070160578 Expansion of natural killer and CD8 T-cells with IL-15R/ligand activator complexes |
| 07/12/2007 | US20070160577 Interleukin-11 compositions and methods of use |
| 07/12/2007 | US20070160576 IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| 07/12/2007 | US20070160575 Anth1 chimeric antagonist |
| 07/12/2007 | US20070160574 Design of CXC chemokine analogs for the treatment of human diseases |
| 07/12/2007 | US20070160573 Peptide conjugated anti-cancer prodrugs |
| 07/12/2007 | US20070160572 Colloidal metal compositions and methods |
| 07/12/2007 | US20070160571 Composition and method for inducing protective vaccine response |
| 07/12/2007 | US20070160570 Chimeric polypeptides containing chemokine domains |
| 07/12/2007 | US20070160568 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof |
| 07/12/2007 | US20070160558 Peptide composition |
| 07/12/2007 | US20070160546 Use of stinging cells/capsules for the delivery of active agents to keratinous substances |
| 07/12/2007 | US20070160545 Method for reducing ultraviolet light induced apoptosis |
| 07/12/2007 | US20070160543 Haemostatic sprays and compositions |
| 07/12/2007 | US20070160539 HPRP4s Modifiers of the p53 Pathway and Methods of Use |
| 07/12/2007 | US20070160538 Antianxiety drugs and a method of screening the same |
| 07/12/2007 | US20070160536 prodrug comprising 8-O-(12[L-leucinoylamino]dodecanoyl)-8-O-debutanoylthapsigargin (L12ADT); and a peptide of sequence Ser-Ser-Lys-Tyr-Gln; peptide is linked to the L12ADT to inhibit the therapeutic activity of the drug; anticarcinogenic agent; benign prostate hyperplasia; prostate and breast cancer |
| 07/12/2007 | US20070160535 Neoplasia, ovarian cancer and skin cancer; radiolabelling |
| 07/12/2007 | US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 07/12/2007 | US20070160533 vascular endothelial growth factor receptor (VEGFR)-binding polypeptides, comprising a fibronectin type III tenth (10Fn3) domain of 80 to 150 amino acids; Angiogenesis |
| 07/12/2007 | US20070160531 Targeting endothelium for tissue-specific delivery of agents |
| 07/12/2007 | US20070160530 Antibodies and molecules derived therefrom that bind to steap-1 proteins |